| |
Latest 10 SEC filings (by transaction date) for PODD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 29/24 | Feb 28/24 | Petrovic Shacey | Direct Ownership | Employee Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -11,609 | |
Feb 29/24 | Feb 28/24 | Petrovic Shacey | Direct Ownership | Common Stock | S - Open market or private sale | -11,609 | $162.92 |
Feb 29/24 | Feb 28/24 | Petrovic Shacey | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,609 | $92.11 |
Feb 29/24 | Feb 28/24 | Singh Prem | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -90 | $163.60 |
Feb 29/24 | Feb 28/24 | Manea Dan | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -168 | $163.60 |
Feb 29/24 | Feb 28/24 | Kapples John W. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -263 | $163.60 |
Feb 29/24 | Feb 28/24 | Hollingshead James | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -908 | $163.60 |
Feb 29/24 | Feb 28/24 | Field Mark N | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -134 | $163.60 |
Feb 29/24 | Feb 28/24 | Cousin Laetitia | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -62 | $163.60 |
Feb 29/24 | Feb 28/24 | Benjamin Eric | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -325 | $163.60 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PODD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 29/24 | Feb 28/24 | Petrovic Shacey | Direct Ownership | Employee Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -11,609 | |
Feb 29/24 | Feb 28/24 | Petrovic Shacey | Direct Ownership | Common Stock | S - Open market or private sale | -11,609 | $162.92 |
Feb 29/24 | Feb 28/24 | Petrovic Shacey | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,609 | $92.11 |
Feb 29/24 | Feb 27/24 | Singh Prem | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 5,031 | |
Feb 29/24 | Feb 28/24 | Singh Prem | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -90 | $163.60 |
Feb 29/24 | Feb 27/24 | Singh Prem | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 2,100 | |
Feb 29/24 | Feb 27/24 | Manea Dan | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 5,390 | |
Feb 29/24 | Feb 28/24 | Manea Dan | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -168 | $163.60 |
Feb 29/24 | Feb 27/24 | Manea Dan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 2,250 | |
Feb 29/24 | Feb 27/24 | Kapples John W. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 6,649 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cencora (N:COR) |
DexCom (OQ:DXCM) |
West Pharmaceutical Servi (N:WST) |